MedinCell publishes its financial results for the first semester of 2022-2023
December 6, 2022
Previous PostPublication of the 2023 financial calendar
Next PostAdditional US$ 4 million received for next development steps of MedinCell's 6-month active injectable bioresorbable subcutaneous contraceptive